CSIMarket
 


Surmodics Inc  (SRDX)
Other Ticker:  
 
 

SRDX's Capital Expenditures Growth by Quarter and Year

Surmodics Inc's Capital Expenditures results by quarter and year




SRDX Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter September 1.22 0.86 0.90 0.32
III Quarter June 0.72 1.16 0.65 0.64
II Quarter March 0.98 0.78 2.32 1.67
I Quarter December 0.57 2.41 1.04 1.86
FY   3.49 5.21 4.91 4.49



SRDX Capital Expenditures fourth quarter 2023 Y/Y Growth Comment
Surmodics Inc achieved in the fourth quarter 2023, above Company average Capital Expenditures rise of 41.63% year on year, to $ 1.22 millions.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 45 other companies have achieved higher Capital Expenditures growth. While Surmodics Inc' s Capital Expenditures jump of 41.63% ranks overall at the positon no. 1263 in the fourth quarter 2023.




SRDX Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter September 41.63 % -4.44 % 181.25 % -68.63 %
III Quarter June -37.93 % 78.46 % 1.56 % -39.05 %
II Quarter March 25.64 % -66.38 % 38.92 % -19.32 %
I Quarter December -76.35 % 131.73 % -44.09 % -14.68 %
FY   -33.05 % 6.11 % 9.35 % -28.96 %

Financial Statements
Surmodics Inc's fourth quarter 2023 Capital Expenditures $ 1.22 millions SRDX's Income Statement
Surmodics Inc's fourth quarter 2022 Capital Expenditures $ 0.86 millions Quarterly SRDX's Income Statement
New: More SRDX's historic Capital Expenditures Growth >>


SRDX Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter September 69.17 % -25.86 % 38.46 % -50 %
III Quarter June -26.53 % 48.72 % -71.98 % -61.68 %
II Quarter March 71.93 % -67.63 % 123.08 % -10.22 %
I Quarter December -33.72 % 167.78 % 225 % 82.35 %
FY (Year on Year)   -33.05 % 6.11 % 9.35 % -28.96 %




Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #46
Healthcare Sector #168
Overall #1263

Capital Expenditures Y/Y Growth Statistics
High Average Low
336.44 % 24.09 % -46.33 %
(Sep 30 2016)   (Sep 30 2022)
Capital Expenditures fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #46
Healthcare Sector #168
Overall #1263
Capital Expenditures Y/Y Growth Statistics
High Average Low
336.44 % 24.09 % -46.33 %
(Sep 30 2016)   (Sep 30 2022)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Surmodics Inc's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
1225 % 64.38 % -100 %
(Mar 31 2014)  


SRDX's IV. Quarter Q/Q Capital Expenditures Comment
Surmodics Inc achieved in the IV. Quarter 2023 above company average sequential Capital Expenditures jump of 69.17%, to $ 1.22 millions, from $0.72 millions in the third quarter.
SRDX is undergoing a remarkable growth, not only recording above regular growth, and additionally improving speed, Hugo Gómez, a business consultant situated in New York mentioned.

Within Medical Equipment & Supplies industry 25 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Surmodics Inc's Capital Expenditures growth quarter on quarter, overall rank is 458.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #26
Healthcare Sector #110
Overall #458
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #26
Healthcare Sector #110
Overall #458
Capital Expenditures Q/Q Growth Statistics
High Average Low
1225 % 64.38 % -100 %
(Mar 31 2014)  


SRDX's IV. Quarter Q/Q Capital Expenditures Comment
Surmodics Inc achieved in the IV. Quarter 2023 above company average sequential Capital Expenditures jump of 69.17%, to $ 1.22 millions, from $0.72 millions in the third quarter.
Medical Equipment & Supplies company is undergoing a remarkable growth, with claiming higher then normal increase, and additionally accelerating speed.

Within Medical Equipment & Supplies industry 25 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Surmodics Inc's Capital Expenditures growth quarter on quarter, overall rank is 458.


Surmodics Inc's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 3.49 $ 3.13 $ 3.57 $ 3.37 $ 5.20
Y / Y Capital Expenditures Growth (TTM) -32.92 % -40.24 % -24.82 % -46.33 % 5.8 %
Year on Year Capital Expenditures Growth Overall Ranking # 1254 # 750 # 1277 # 2337 # 1550
Seqeuential Capital Expenditures Change (TTM) 11.39 % -12.12 % 5.79 % -35.23 % -0.76 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1411 # 902 # 1831 # 2772 # 1801




Cumulative Capital Expenditures growth Comment
Surmodics Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Mar 31 2023. If the fiscal year would end in Sep 30 2023, Surmodics Inc's annual Capital Expenditures decline would be -32.92% year on year to $3 millions.

In the Healthcare sector 169 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 750 to 1254.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
336.44 %
24.09 %
-46.33 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 56
Healthcare Sector # 170
Overall # 1254

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
336.44 %
24.09 %
-46.33 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 56
Sector # 186
S&P 500 # 1411
Cumulative Capital Expenditures growth Comment
Surmodics Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Mar 31 2023. If the fiscal year would end in Sep 30 2023, Surmodics Inc's annual Capital Expenditures drop would be -32.92% year on year to $3 millions.

In the Healthcare sector 169 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 750 to 1254.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
336.44 %
24.09 %
-46.33 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 56
Healthcare Sector # 170
Overall # 1254

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
336.44 %
24.09 %
-46.33 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 56
Sector # 186
S&P 500 # 1411




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
SRDX's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for SRDX's Competitors
Capital Expenditures Growth for Surmodics Inc's Suppliers
Capital Expenditures Growth for SRDX's Customers

You may also want to know
SRDX's Annual Growth Rates SRDX's Profitability Ratios SRDX's Asset Turnover Ratio SRDX's Dividend Growth
SRDX's Roe SRDX's Valuation Ratios SRDX's Financial Strength Ratios SRDX's Dividend Payout Ratio
SRDX's Roa SRDX's Inventory Turnover Ratio SRDX's Growth Rates SRDX's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Acadia Healthcare Company Inc 67.72%$ 67.720 millions
Blueprint Medicines Corporation67.63%$ 67.632 millions
Henry Schein Inc66.67%$ 66.667 millions
West Pharmaceutical Services Inc 65.74%$ 65.744 millions
Schrodinger Inc 64.01%$ 64.009 millions
Veracyte inc 63.48%$ 63.477 millions
Radnet Inc 60.93%$ 60.932 millions
Moderna Inc 57.30%$ 57.303 millions
Eli Lilly And Company57.21%$ 57.210 millions
Agilon Health Inc 57.20%$ 57.201 millions
Vor Biopharma Inc 56.04%$ 56.040 millions
Lifevantage Corp55.85%$ 55.846 millions
Yunhong Green Cti Ltd 55.56%$ 55.556 millions
Amgen Inc 55.00%$ 55.000 millions
Vivos Therapeutics Inc 54.00%$ 54.000 millions
Beigene ltd 53.97%$ 53.969 millions
Hyperfine Inc 52.02%$ 52.023 millions
Intuitive Surgical Inc 51.57%$ 51.567 millions
Precision Optics Corporation Inc 49.16%$ 49.164 millions
Biogen Inc 48.22%$ 48.223 millions
Acorda Therapeutics Inc 46.67%$ 46.667 millions
Femasys Inc 46.54%$ 46.543 millions
Staar Surgical Company46.42%$ 46.421 millions
Livanova Plc44.31%$ 44.314 millions
Seres Therapeutics Inc 44.11%$ 44.106 millions
Abcellera Biologics Inc 43.95%$ 43.947 millions
Eyepoint Pharmaceuticals Inc 43.57%$ 43.573 millions
Irhythm Technologies Inc 43.49%$ 43.486 millions
Veru Inc 43.05%$ 43.054 millions
Integra Lifesciences Holdings Corp42.85%$ 42.851 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com